1477 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Ocumension Therapeutics engages in the identification, development, and commercialization of ophthalmic therapies. The company was founded in 2017 and is headquartered in Suzhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
1477 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company